NCT07532148 2026-04-15
Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Chong Kun Dang Pharmaceutical
Phase 1 Not yet recruiting
Clinical Trials
9 trialsNCT07524322 2026-04-13
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Regor Pharmaceuticals Inc.
Phase 1 Not yet recruiting
NCT07489287 2026-03-27
GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer
Roswell Park Cancer Institute
Phase 1 Not yet recruiting
NCT07462468 2026-03-13
A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.
WestVac Biopharma Co., Ltd.
Phase 1 Not yet recruiting
NCT07088588 2025-07-28
Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
Phase 1 Not yet recruiting
NCT06846424 2025-02-26
SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer
Shanghai Gynecologic Oncology Group
Phase 1 Not yet recruiting
NCT06754761 2025-01-01
Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of Ceralasertib
AstraZeneca
Phase 1 Not yet recruiting
NCT06652529 2024-11-07
AROG4-01-01
Aromics Therapeutics
Phase 1 Not yet recruiting
NCT06383507 2024-04-25
A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors
Zhejiang University
Phase 1 Not yet recruiting